Keynote and technical sessions showcased rapid advances — pluripotent stem cells, organoids, extracellular vesicles — and stressed deep product characterization, robust potency assays and manufacturing scale‑up as prerequisites for safe clinical translation.

Revolutionize drug development using advanced cell-based assays with flow cytometry expertise, offering unparalleled organ mimicry and functional complexity.